{"id":13296,"date":"2024-08-23T01:57:10","date_gmt":"2024-08-22T23:57:10","guid":{"rendered":"https:\/\/valintermed.com\/?p=13296"},"modified":"2024-08-23T01:57:10","modified_gmt":"2024-08-22T23:57:10","slug":"bolezn-fogta-koyanagi-harada","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/koyanagi-harada-s-fog-disease\/","title":{"rendered":"Vogt-Koyanagi-Harada disease"},"content":{"rendered":"
<\/div>\n

Vogt-Koyanagi-Harada disease (VKH) is an autoimmune disorder characterized by multisystemic lesions, including inflammation of the uveal tract of the eye, skin, and auditory apparatus, as well as neuritis. It is a rare but serious pathology that usually affects young and middle-aged people, mainly between the ages of 20 and 50. This disease most often affects representatives of Asian and Hispanic peoples. The basis of the pathogenesis of the disease is the autoimmune response of the body, in which the immune system mistakenly attacks its own cells. The severity of the disease and the range of manifestations vary from patient to patient, which determines its relevance and complexity in terms of diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n